Novavax Inc (NVAX)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$9.20

Buy

$9.24

arrow-down$-0.33 (-3.46%)

Prices updated at 25 Jan 2025, 00:58 EST
| Prices minimum 15 mins delay
|
Prices in USD
Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
NASDAQ
arrow-down-0.5%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$9.80 - $9.06
$23.86 - $3.53
-
1,476.91m
-
-
4,423,007
-
8,932,653.68
3.06
140.51m
US6700024010
-2.18
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.